Health Care: Drugs

Nivalis Therapeutics Inc (NVLS: NASDAQ)

$4.43 -0.43 | -8.85%
02/08/16 - 03:59 PM ET
Company Income Statement
Dec 2014
Sales 0.00
Cost of Sales 0.00
Gross Operating Profit 0.00
Selling, General, and Administrative Expenses 2.29M
Research & Development 12.20M
Operating Income before D & A (EBITDA) -14.49M
Depreciation & Amortization 794.96K
Interest Income 0.00
Other Income - Net 296.34K
Special Income / Charges 0.00
Total Income Before Interest Expenses (EBIT) -14.99M
Interest Expense 845.10K
Pre-Tax Income -15.83M
Income Taxes 0.00
Minority Interest 0.00
Net Income From Continuing Operations -15.04M
Net Income From Discontinued Operations 0.00
Net Income From Total Operations -15.04M
Extraordinary Income/Losses 0.00
Income From Cum. Effect of Acct. Change 0.00
Income From Tax Loss Carryforward 0.00
Other Gains / Losses 0.00
Total Net Income -15.04M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
Preferred Dividends
Net Income Available To Common -15.04M
Basic EPS from Continuing Ops. -1.92
Basic EPS from Discontinued Ops. 0.00
Basic EPS from Total Operations -1.92
Basic EPS from Extraordinary Inc. 0.00
Basic EPS from Cum Effect of Accounting Change 0.00
Basic EPS from Tax Loss Carryf'd. 0.00
Basic EPS from Other Gains (Losses) 0.00
Basic EPS, Total -1.92
Basic Normalized Net Income/Share -1.92
EPS fr Continuing Ops. -1.92
EPS fr Discontinued Ops 0.00
EPS fr Total Ops. -1.92
EPS fr Extraord. Inc. 0.00
EPS fr Cum Effect of Accounting Change 0.00
EPS fr Tax Loss Carfd. 0.00
EPS fr Other Gains (L) 0.00
EPS, Total -1.92
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
Dividends Paid per Share 0.00

Portfolios with NVLS

Latest NVLS Headlines from TheStreet

More Financial News for NVLS

Press Releases for NVLS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter